Antihypertensive drugs in very old people: A subgroup meta-analysis of randomised controlled trials

Lancet

Volumn 353, Issue 9155, 1999, Pages 793-796

  Gueyffier, François ^g   Bulpitt, Christopher ^a   Boissel, Jean Pierre ^c   Schron, Eleanor ^b   Ekbom, Tord ^c   Fagard, Robert ^d   Casiglia, Edoardo ^c   Kerlikowske, Karla ^e   Coope, John ^f  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c Dept of Community Health Sciences ^*

^d Hypertension Cardiovasc Rehab U   (Belgium)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f Bollington Medical Centre   (United Kingdom)

^g Service de Pharmacologie Clinique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ARTICLE; CAUSE OF DEATH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; ELDERLY CARE; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE;

EID: 0033528524     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)08127-6     Document Type: Article

References (32)

1. Hypertension Detection and Follow-up Program Co-operative Group. Five-year findings of the Hypertension Detection and Follow-up Program - I: reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979; 242: 2362-71.
2. Report by the Management Committee. The Australian therapeutic trial in mild hypertension. Lancet 1980; i: 1261-67.
3. Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ 1985; 291: 97-104.
4. Mulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly: implications and generalizability of randomized trials. JAMA 1994; 272: 1932-38.
5. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-64.
6. Staessen JA, Fagard R, Thijs L, et al, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-64.
7. Gueyffier F, Froment A, Gouton M. New meta-analysis of treatment of hypertension: improving the estimate of therapeutic benefit. J Hum Hypertens 1996; 10: 1-8.
8. Amery A, Birkenhäger W, Brixko P, et al. Influence of antihypertensive drug treatment on morbidity and mortality in patients over the age of 60 years: EWPHW results: sub-group analysis based on entry stratification. J Hypertens 1986; 4 (suppl 6): S642-47.
9. Bulpitt CJ, Fletcher AE, Amery A, et al. The Hypertension in the Very Elderly Trial (HYVET). J Hum Hypertens 1994; 8: 631-32.
10. Bulpitt CJ, Fletcher AE, Amery A, et al. The Hypertension in the Very Elderly Trial (HYVET): rationale, methodology and comparison with previous trials. Drugs Aging 1994; 5: 171-83.
11. Mulrow C, Lau J, Cornell J, Brand M, Amato M. Antihypertensive drug therapy in the elderly. In: Gueyffier F, Lau J, Mulrow C, eds. Hypertension module of the Cochrane Database of Systemic Reviews: The Cochrane Library, The Cochrane Collaboration. London: BMJ Publishing Group, 1998.
12. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 1991; 10: 1665-77.
13. Casiglia E, Spolaore P, Mazza A, Ginocchio G, Colangeli G, Onesto C, et al. Effect of two different therapeutic approaches on total and cardiovascular mortality in a cardiovascular study in the elderly (CASTEL). Jpn Heart J 1994; 35: 589-600.
14. Cucherat M, Boissel JP, Leizorovicz A. La méta-analyse des essais thérapeutiques. Paris: Masson Ed, 1997.
15. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults; principal results. BMJ 1992; 304: 405-12.
16. Sprackling ME, Mitchell JRA, Short AH, Watt G. Blood pressure reduction in the elderly: a randomised controlled trial of methyldopa. BMJ 1981; 283: 1151-53.
17. Veterans Administration Co-operative Study Group on antihypertensive agents. Effect of treatment on morbidity in hypertension: results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 1970; 213: 1143-52.
18. Carter AB. Hypertensive therapy in stroke survivors. Lancet 1970; i: 485-89.
19. Hypertension Stroke Co-operative Study Group. Effect of antihypertensive treatment on stroke recurrence. JAMA 1974; 229: 409-18.
20. Kuramoto K, Matsushita S, Kuwajima T, Murakami M. Prospective study on the treatment of mild hypertension in the aged. Jpn Heart J 1981; 22: 75-85.
21. Gueyffier F, Boutitie F, Boissel JP, et al. INDANA; a meta-analysis on individual patient data in hypertension: protocol and preliminary results. Therapie 1995; 50: 353-62.
22. Amery A, Birkenhäger W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet 1985; i: 1349-54.
23. Coope J, Warrender TS. Randomised trial of treatment of hypertension in elderly patients in primary care. BMJ 1986; 293: 1145-51.
24. Perry HM Jr, Smith WM, McDonald RH, et al. Morbidity and mortality in the Systolic Hypertension in the Elderly Program Pilot Study. Stroke 1989; 20: 4-13.
25. Dahlöf B, Hansson L, Lindholm LH, Scherstén B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-85.
26. Boissel JP, Blanchard J, Panak E, Peyrieux JC, Sacks H. Considerations for the meta-analysis of randomized clinical trials: summary of a panel discussion. Control Clin Trials 1989; 10: 254-81.
27. Lenfant C. US initiative to target congestive heart failure. World Hypertens League Newsletter 1997; 52: 1-3.
28. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 490-98.
29. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure: collaborative group on ACE inhibitor trials. JAMA 1995; 273: 1450-56.
30. Bulpitt CJ, Fletcher AE. Quality-of-life instruments in hypertension. Pharmacoeconomics 1994; 6: 523-35.
31. Fanshel S, Bush JW. A heath status index and its application to heath services outcomes. Operation Res 1970; 18: 1021-66.
32. Bulpitt CJ. Quality of life in hypertensive patients. In: Amery A, Fagard R, Lijnen P, et al, eds. Hypertensive cardiovascular disease: pathophysiology and treatment. The Hague: Martinus Nijhoff, 1982: 929-48.